The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Metsera, Inc. aims to raise $275 million in an IPO to fund its clinical-stage biopharma programs targeting obesity and ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

PMGC Holdings Inc. (NASDAQ: ELAB) shares are trading higher Friday after the company announced that its subsidiary, ...

BusinessWire India New Delhi [India]7 This Republic Day Dr Morepen NSEMOREPENLAB a name synonymous with trust and innovation ...

You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate ...

Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results ...

Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

President Trump’s health secretary nominee, Robert F. Kennedy Jr., on Wednesday said vaccines are a critical component of ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

In November 2023 Colombia imposed a tax on highly processed foods and drinks. Authorities in Brazil, Canada and Peru have ...

NHS semaglutide spending in London has surged from £242K in 2019 to £15.6m in 2024. Find out what's driving demand and the ...